Insmed (INSM) Profit After Tax (2010 - 2026)
Insmed's (INSM) quarterly Profit After Tax came in at -$1.5 million in Q1 2026, up 99.43% year-on-year from -$730574.3 in Q1 2025, and up 99.55% quarter-over-quarter from -$324.7 million in Q4 2025.
Insmed (INSM) Profit After Tax (2010 - 2026) Analysis & Trends
Insmed's Profit After Tax history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 99.43% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$693.6 million, a 31.65% increase from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 39.08% from the prior year.
- Profit After Tax climbed to -$1.5 million in Q1 2026 per INSM's latest filing, from -$324.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $562.0 million in Q4 2023 and bottomed at -$370.0 million in Q3 2025.
- The 5-year median for Profit After Tax is -$157.8 million (2022), against an average of -$123.1 million.
- Across the five-year window, Profit After Tax plunged 40517.9% in 2022 and jumped 456.22% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$157.8 million in 2022, then soared by 456.22% to $562.0 million in 2023, then plunged by 142.19% to -$237.1 million in 2024, then sank by 36.97% to -$324.7 million in 2025, then surged by 99.55% to -$1.5 million in 2026.
- Per Business Quant, the three latest INSM Profit After Tax figures stand at -$1.5 million (Q1 2026), -$324.7 million (Q4 2025), and -$370.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | -324.74 Mn |
| Sep 30, 2025 | -370.02 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | -256.58 Mn |
| Dec 31, 2024 | -237.09 Mn |
| Sep 30, 2024 | -220.52 Mn |
| Jun 30, 2024 | -300.61 Mn |
| Mar 31, 2024 | -157.09 Mn |
| Dec 31, 2023 | 562.01 Mn |
| Sep 30, 2023 | -827,000.00 |
| Jun 30, 2023 | -244.81 Mn |
| Mar 31, 2023 | -159.44 Mn |
| Dec 31, 2022 | -157.77 Mn |
| Sep 30, 2022 | -131.60 Mn |
| Jun 30, 2022 | -699,000.00 |
| Mar 31, 2022 | -94.62 Mn |
| Dec 31, 2021 | -433.79 Mn |
| Sep 30, 2021 | -324,000.00 |
| Jun 30, 2021 | 334,000.00 |